SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Guggenheim Upgrades Amneal Pharmaceuticals to Neutral

Guggenheim upgrades Amneal Pharmaceuticals (NYSE:AMRX) from Sell to Neutral.

Benzinga · 05/12/2020 11:27

Guggenheim upgrades Amneal Pharmaceuticals (NYSE:AMRX) from Sell to Neutral.